Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.65 USD | +1.07% |
|
-7.53% | +32.01% |
Jun. 12 | Lantern Pharma Secures Composition of Matter Patent for LP-284 in Japan | MT |
May. 29 | Transcript : Lantern Pharma Inc. - Special Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+32.01% | 60.79M | |
+48.54% | 56.61B | |
+37.15% | 39.25B | |
-6.02% | 39.62B | |
-6.90% | 28.28B | |
+12.97% | 26.44B | |
-16.91% | 20.12B | |
+31.71% | 12.48B | |
+28.18% | 12.51B | |
+0.38% | 12.2B |
- Stock Market
- Equities
- LTRN Stock
- News Lantern Pharma Inc.
- FDA Clears Lantern Pharma's Investigation New-Drug Application for LP-284